Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.
Research Interests

Papers共 98 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Effect of Sacubitril/Valsartan on Patients Having Heart Failure With Preserved Left Ventricular Ejection Fraction Undergoing Hemodialysis: A Long-term Observational Study
AKIRA MIMA, HIDEMASA GOTODA,SHINJI LEE,RINA LEE,AMI MURAKAMI,RYOSUKE AKAI, SAYUMI KIDOOKA, KEISHI MATSUMOTO, YUTA SAITO, SHINJI HISHIDA, TAKAHIRO NAKAMOTO, SUGURU KIDO,
In Vivono. 3 (2024): 1266-1270
Cited0Views0Bibtex
0
0
Effect of Sacubitril/Valsartan on Patients Having Heart Failure With Preserved Left Ventricular Ejection Fraction Undergoing Hemodialysis: A Long-term Observational Study
Akira Mima,Hidemasa Gotoda,Shinji Lee,Rina Lee,Ami Murakami,Ryosuke Akai, Sayumi Kidooka, Keishi Matsumoto, Yuta Saito, Shinji Hishida, Takahiro Nakamoto, Suguru Kido,
In vivo (Athens, Greece)no. 3 (2024): 1266-1270
Cited0Views0WOSBibtex
0
0
Efficacy and Safety of Vildagliptin for Type 2 Diabetes in Patients With Diabetic Kidney Disease
Akira Mima, Takahiro Nakamoto, Yuta Saito, Keishi Matsumoto, Shinji Lee
In vivo (Athens, Greece)no. 4 (2024): 1829-1833
Cited0Views0WOSBibtex
0
0
Effect of finerenone on nephrotic syndrome in patients with diabetic kidney disease
Akira Mima, Yuta Saito, Keishi Matsumoto, Takahiro Nakamoto,Shinji Lee
Metabolism open (2024): 100294-100294
Cited0Views0WOSBibtex
0
0
Safety and Efficacy of Imeglimin for Type 2 Diabetes in Patients Undergoing Dialysis
Akira Mima
In vivo (Athens, Greece)no. 3 (2023): 1334-1338
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics
  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn